ADVFN - Advanced Financial Network.
HOME» NASDAQ » M » MYL Stock Price » MYL Stock News

Mylan Inc. Share News

 Mylan Inc. (mm) Stock Price
MYL Stock Price
 Mylan Inc. (mm) Stock Chart
MYL Stock Chart
 Mylan Inc. (mm) Stock News
MYL Stock News
 Mylan Inc. (mm) Company Information
MYL Company Information
 Mylan Inc. (mm) Stock Trades
MYL Stock Trades

Mylan Confirms Endo Suit Over Generic Migraine Drug Application

DOW JONES NEWSWIRES Mylan Inc. (MYL) confirmed Wednesday that it has been sued by Endo Pharmaceuticals Holdings Inc. (ENDP) over its application for approval of a generic drug used to treat acute migraine headaches in adults. Mylan--one of the world's largest generic drug makers--said it believes it is the first company to file a substantially complete application for approval of frovatriptan succinate EQ, a generic version of Frova. The company said it expects to qualify for 180 days of marketing exclusivity upon final approval from the Food and Drug Administration. Mylan, which has had litigation-related charges figure prominently in its recent quarterly results, last month reported second-quarter earnings surged 70% as sales got a lift from a weaker dollar. Shares closed Tuesday at $20.01 and were inactive in recent premarket trade. Through the latest close, the stock is down 5.3% since the start of the year. -By Mia Lamar, Dow Jones Newswires; 212-416-3207; mia.lamar@dowjones.com

Stock News for Mylan Inc. (MYL)
DateTimeHeadline
06/19/201517:23:15Current Report Filing (8-k)
06/19/201517:22:22Proxy Soliciting Materials (revised) (prer14a)
06/19/201517:20:38Registration Statement for Securities to Be Issued in Business...
06/19/201512:32:05Filing of Certain Prospectuses and Communications in Connection...
06/19/201509:30:04Teva Takes 4.6% Stake in Mylan
06/18/201515:50:25Teva's Copaxone Patent Loses Again
06/18/201511:55:00U.S. Court of Appeals for the Federal Circuit Finds Teva's '808...
06/18/201511:23:25Amended Statement of Beneficial Ownership (sc 13d/a)
06/16/201519:01:40Statement of Changes in Beneficial Ownership (4)
06/16/201509:19:00Mylan Issues Statement in Response to Abbott's Support for Perrigo...
06/16/201508:42:00Pulmatrix and Mylan Enter Into ex-U.S. Development Agreement...
06/16/201507:30:00Pulmatrix and Mylan Enter Into ex-U.S. Development Agreement...
06/15/201515:39:39Current Report Filing (8-k)
06/12/201519:03:07Statement of Changes in Beneficial Ownership (4)
06/12/201519:02:10Statement of Changes in Beneficial Ownership (4)
06/12/201519:02:10Statement of Changes in Beneficial Ownership (4)
06/12/201519:01:41Statement of Changes in Beneficial Ownership (4)
06/12/201519:01:13Statement of Changes in Beneficial Ownership (4)
06/11/201517:24:26Current Report Filing (8-k)
06/09/201521:50:23Judge Recommends Barring Law Firm From Teva-Mylan Takeover Fight

Mylan Inc. and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad